User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

3540

Interactions with Platform & by Email *

INTERACTIONS

637

Unique # Participated *

PARTICIPANTS

106

Responses Validated *

VALIDATIONS

31

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Prelude.....II-11$100
   Expanding Application Base as the Major Growth Driver.....II-21$100
   Current and Future Analysis.....II-31$100
   Competitive Landscape – Expanding Applications Attract New Players.....II-42$200
   Optical In-Vitro Diagnostics – The Largest Market Segment for Biophotonics.....II-6
Increasing Penetration of Diabetes Mellitus – Offers Opportunities for
  Biophotonics.....II-6
1$100
   Global Diabetic Statistics – Opportunity Indicators.....II-7
Table 1: Worldwide Prevalence of Diabetes Mellitus by Region (2014 & 2035P) (includes corresponding Graph/Chart).....II-7
1$350
   Table 2: Ten Countries with the Highest DM Cases (2014) (includes corresponding Graph/Chart).....II-8
Endoscopy – A Market with Immense Scope.....II-8
Ophthalmology and Dermatology Major Application Segments for Medical Lasers.....II-8
1$350
   Food Diagnostics – An Emerging Niche.....II-9
Drug Discovery & Development – A Potential Application Segment for Biophotonics.....II-9
Opportunities Galore for Biophotonic Technologies in Infection Control.....II-9
1$100
   High-end Biophotonics to Find Major Application in Neurosciences.....II-101$100
   Coherent Develops Genetically Encoded Ultrafast Fiber Laser for Application in
  Neuroscience.....II-11
Improving Healthcare Expenditure to Drive Demand for Biophotonics.....II-11
2$200
   Table 3: Per-Capita Healthcare Expenditure in Select Regions (2014) (includes corresponding Graph/Chart).....II-131$350
   Table 4: Healthcare Spending as a Percentage of GDP by Geographic Region (2015E) (includes corresponding Graph/Chart).....II-14
Ageing Population to Spruce Up Biophotonics Development.....II-14
2$350
   Demographic Statistics - Opportunity Indicators for Biophotonics Market:.....II-16
Table 5: Global Population Statistics for the 65+ Age Group (2013) (includes corresponding Graph/Chart).....II-16
1$350
   Table 6: Elderly Population (60+ Years) as a Percentage of the Total Population (2012 & 2050) (includes corresponding Graph/Chart).....II-17
Growing Prominence of Biophotonics in Cancer Detection.....II-17
1$350
   Cancer Incidence and Mortality Statistics – A Perspective of Market Potential.....II-18
Table 7: Worldwide Incidence of Cancer (2012, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart).....II-18

Table 8: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart).....II-18
1$350
   Table 9: Global Cancer Incidence by Income Group: 2012 (in Thousands) (includes corresponding Graph/Chart).....II-19

Table 10: World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths (in Thousands) for Asia-Oceania, Europe, North America, Latin America & Caribbean, and Africa (includes corresponding Graph/Chart).....II-19
1$350
   Table 11: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal and Liver Cancers (includes corresponding Graph/Chart).....II-20

Table 12: Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus and Liver Cancers (includes corresponding Graph/Chart).....II-20
Cancer Prone Sites based on Age.....II-20
1$350
   Biophotonics-based Tests for Detecting Coronary Artery Diseases.....II-21
Photonics-based Breath Analysis Gaining Traction.....II-21
OMI to Revolutionize Methodologies for Diagnosing and Treating Diseases.....II-21
1$100
   Advancements in Optical Filter Technology to Revolutionize Wearable Electronics and
  PoC Diagnostics.....II-22
2$200
   Diagnostic & Therapeutic Applications of Biophotonics Attract R&D Funding.....II-24
Private Foundations Come Forth to Invest in Biophotonics.....II-24
1$100
   Notable Technology Innovations and Research Advancements in the Biophotonics
  Field.....II-25
CBSS Develops Optical Microscopes for Disease Diagnosis & Treatment.....II-25
University of Adelaide Focuses on Biophotonics for Research on Life Processes.....II-25
1$100
   Texas A&M University’s Invests in Multidisciplinary Biophotonics Research.....II-26
NSF Grants Funds for Biomolecule Imaging using X-Ray Lasers.....II-26
Photoplethysmography-Based DistancePPG to Aid in Monitoring Vital Signs.....II-26
Permanent Fluorescent Label Helps Researchers in Studying Neural Activities.....II-26
1$100
   Researchers Develop Glucolight System for Non- Invasive Measurement of Blood Glucose
  Levels.....II-27
Researchers Develop SCAPE Microscopy for 3D Imaging of Moving Samples.....II-27
1$100
   Japanese Researchers Develop Nanolaser to Identify Specific Biomolecules.....II-28
Novel Phototherapy and Imaging Technique to Target and Destroy Cancer Cells.....II-28
1$100
   Researchers Develop Multicolor RGB Marking to Color-Code Neural Cells.....II-29
EHT Model Holds Potential to Enable Tailored Optogenetics Proteins.....II-29
Researchers at University of Buffalo to Develop Endoscope for High-Contrast Imaging of
  Cancer Tumors.....II-29
1$100
   Photoacoustic Imaging to Provide Effective Solution to Detect Cervical Cancer.....II-30
Photoacoustic Device Allows Researchers to Diagnose Melanoma.....II-30
LIAFS/DRS Technique to Improve Melanoma Diagnosis.....II-30
1$100
   Raman Spectroscopy Enables Faster, Accurate Diagnosis of Cancer.....II-31
Light-based Approaches to Help Researchers in Studying Brain Function.....II-31
1$100
   Researchers Develop Lens-Free On-Chip Microscope to Produce High-Resolution
  Images.....II-32
Fluorescent Dye-Coated Nanoparticles to Target Disease Causing Genes.....II-32
UK Sets Up Quantum Technology Research Hubs to Explore Light Detectors.....II-32
1$100
   Stimulation of Receptors Using Light to Relax Blood Vessels.....II-33
MIR Laser Produces X-Ray Pulses with High Flux.....II-33
Phosphorescent Bandage to Monitor Oxygen Concentration for Wound Assessment.....II-33
1$100
   Sophisticated Microscopy Technique to Enable Single- Cell, High-Resolution Imaging of
  Entire Body.....II-34
1$100
   Violet-Blue Light Controlled Medicine to Provide Effective Treatment Option for
  Diabetic Patients.....II-35
Magnetic Nanoparticles to Assist Researchers in Bio-Imaging Applications.....II-35
1$100
   UV Light with Manual Cleaning to Prevent Spread of Superbugs in Hospitals.....II-36
Researchers Explore Use of OCT to Understand Acne Lesion.....II-36
Novel Fluorescent Probes to Enable Detection of Lysosomal pH Levels.....II-36
1$100
   Researchers Develop New Range of Fluorescence Markers for Imaging
  Applications.....II-37
Researchers Develop Optogenetic Technique to Map Neural Networks.....II-37
1$100
   IR Quantum Cascade Laser to Provide Convenient Solution to Monitor Blood Glucose
  Levels.....II-38
Wearable Optical Device to Enable Timely Identification of Diabetes
  Complication.....II-38
1$100
   New Fluorescence-enhanced Test to Identify People at Higher Risk of Developing
  Diabetes.....II-39
Fluorescence Imaging Techniques to Detect Alzheimer’s Indicators in Eye.....II-39
Adaptive Optics Allows Physicians to Detect Early Signs of Diabetes Eye
  Damage.....II-39
1$100
   New Technique Uses Femtosecond Lasers for Controlled, Precise Drug Delivery.....II-401$100
   Definition.....II-41
Select Light Sources for Biophotonics.....II-41
Gas Lasers.....II-41
1$100
   Diode Lasers.....II-42
Applications.....II-42
Biophotonics in Diagnostics.....II-42
Biophotonics in Therapeutics.....II-42
1$100
   Biophotonics in Biotechnology.....II-43
Other Emerging Applications of Biophotonics.....II-43
Optical Sectional Microscopy.....II-43
Photon Limited Microscopy.....II-43
Fluorescence Microscopy.....II-43
Time-Resolved Fluorescence Spectroscopy.....II-43
1$100
   Fluorescence Lifetime Imaging Microscopy.....II-44
Caged Bioactive Probes.....II-44
End-Use Sectors.....II-44
1$100
   Taiwan Biophotonic Unveils DOE Reflective Sensor for Fingerless Wrist-Worn Pulse
  Oximeters.....II-45
Lumenis Introduces New ResurFX System for Skin Resurfacing Treatment.....II-45
Olympus Introduces Two New Configurations to its FLUOVIEW FVMPE-RS Series.....II-45
KLOX Technologies Obtains CE Mark for LumiHeal™ Medical Device.....II-45
AdvanDx Obtains FDA Approval for mecA XpressFISH™.....II-45
BIOLASE Unveils EPIC™ X Diode Laser.....II-45
1$100
   BioTek Unveils New Cytation Imaging Multi-Mode Reader.....II-46
Lumenis to Launch LightSheer® DESIRE™ and LightSheer® INFINITY™ in Europe.....II-46
Lumenis Unveils New Q-Switched Nd:YAG Module for the M22™ Platform.....II-46
Lumenis Launches LightSheer® DESIRE™ and LightSheer® INFINITY™ Laser Hair Removal
  Systems.....II-46
Picoquant Unveils Picosecond Pulsed Diode Laser Head.....II-46
Biophotas Launches Celluma™ ELITE for Aesthetic Physician Market.....II-46
AdvanDx Introduces Candida QuickFISH Rapid Diagnostic.....II-46
1$100
   AdvanDx Introduces Gram-Negative QuickFISH BC.....II-47
AdvanDx Launches Enterococcus QuickFISH BC.....II-47
BIOLASE Receives License to Sell EPIC 10 Soft-Tissue Diode Laser in Canada.....II-47
Lumenis to Introduce ResurFX™.....II-47
1$100
   Newport Corporation to Acquire FEMTOLASERS.....II-48
Hamilton Thorne Takes Over CRi’s Reproductive Imaging Product Range.....II-48
The University of St Andrews Enters into Partnership with M Squared Lasers.....II-48
Edmund Optics Enters into Partnership with Luxexcel Group.....II-48
First Light Imaging Obtains EC Grant for Working on IR Camera.....II-48
Excelitas Technologies Collaborates with Kinetic River Corp to Design Flow Cytometer
  Prototype.....II-48
Horiba Acquires Photon Technology International.....II-48
1$100
   Newport Takes Over V-Gen.....II-49
Zecotek Signs Joint Collaboration Agreement with Hamamatsu Photonics.....II-49
Bausch + Lomb to Take Over Technolas Perfect Vision GmbH.....II-49
1$100
   AdvanDx, Inc. (US).....II-50
Affymetrix, Inc. (US).....II-50
Andor Technology plc (Ireland).....II-50
1$100
   Becton, Dickinson and Company (US).....II-51
BioTek Instruments, Inc. (US).....II-51
BIOLASE, Inc. (US).....II-51
1$100
   Carl Zeiss MicroImaging GmbH (Germany).....II-52
CEA-Leti (France).....II-52
Endra, Inc. (US).....II-52
1$100
   Epi-Light Limited (Ireland).....II-53
FEI Company (US).....II-53
1$100
   Glenbrook Technologies, Inc. (US).....II-54
Hamamatsu Photonics K.K. (Japan).....II-54
HORIBA, Ltd. (Japan).....II-54
1$100
   Lumenis Ltd. (Israel).....II-55
Newport Corporation (US).....II-55
Ocean Optics, Inc. (US).....II-55
1$100
   Olympus America, Inc. (US).....II-56
PerkinElmer, Inc. (US).....II-56
Photocure ASA (Norway).....II-56
1$100
   PicoQuant GmbH (Germany).....II-57
Solta Medical, Inc. (US).....II-57
Zecotek Photonics, Inc. (Singapore).....II-57
1$100
   Zenalux Biomedical, Inc. (US).....II-581$100
   Table 13: World Recent Past, Current and Future Analysis for Biophotonics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-591$350
   Table 14: World Historic Review for Biophotonics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-601$350
   Table 15: World 14-Year Perspective for Biophotonics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-611$350
   Biophotonics Market Analytics by End-Use Sector.....II-62
Table 16: World Recent Past, Current and Future Analysis for Medical Applications of Biophotonics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-62
1$350
   Table 17: World Historic Review for Medical Applications of Biophotonics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-631$350
   Table 18: World 14-Year Perspective for Medical Applications of Biophotonics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-641$350
   Table 19: World Recent Past, Current and Future Analysis for Biophotonics in Medical Therapeutics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-651$350
   Table 20: World Historic Review for Biophotonics in Medical Therapeutics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-661$350
   Table 21: World 14-Year Perspective for Biophotonics in Medical Therapeutics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-671$350
   Table 22: World Recent Past, Current and Future Analysis for Biophotonics in Medical Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-681$350
   Table 23: World Historic Review for Biophotonics in Medical Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-691$350
   Table 24: World 14-Year Perspective for Biophotonics in Medical Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-701$350
   Table 25: World Recent Past, Current and Future Analysis for Other Medical Biophotonics Applications by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-711$350
   Table 26: World Historic Review for Other Medical Biophotonics Applications by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-721$350
   Table 27: World 14-Year Perspective for Other Medical Biophotonics Applications by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-731$350
   Table 28: World Recent Past, Current and Future Analysis for Non-Medical Applications of Biophotonics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-741$350
   Table 29: World Historic Review for Non-Medical Applications of Biophotonics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-751$350
   Table 30: World 14-Year Perspective for Non-Medical Applications of Biophotonics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-761$350
   A. Market Analysis.....III-1
Outlook.....III-1
Biophotonics for Medical Devices.....III-1
1$75
   Life Science Research Tools Benefit from Photonics Technology.....III-2
Rapidly Aging Demographics: A Major Driving Factor.....III-2
1$75
   Table 31: North American Elderly Population by Age Group (1975-2050) (includes corresponding Graph/Chart).....III-3
Rising Incidences of Chronic Diseases Enhance Demand for Biophotonics.....III-3
Cancer Prevalence Statistics in the US – Growth Opportunities for
  Biophotonics.....III-3
1$200
   Table 32: New Cancer Cases in US by State: 2014 (includes corresponding Graph/Chart).....III-41$200
   Table 33: Number of Deaths Related to Major Types of Cancer in US by State: 2014 (includes corresponding Graph/Chart).....III-51$200
   Table 34: New Cancer Cases in the US by Gender and Affected Site: 2014 (includes corresponding Graph/Chart).....III-61$200
   Table 35: US Cancer Incidence for All Body Sites by Gender & Age Group (2013): New Cancer Cases for Males & Females for the Age groups Under 45 years; 45 years and Above; Under 65 years; and 65 years and Above (includes corresponding Graph/Chart).....III-7
Prevalence of Diabetes Mellitus in North America.....III-7
1$200
   Table 36: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in North America and Caribbean (2014): Breakdown by Country/ Territory (in 000 People & %).....III-81$200
   Product Launches.....III-91$75
   Strategic Corporate Developments.....III-101$75
   Select Players.....III-116$450
   B. Market Analytics.....III-17
Table 37: US Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-17
1$200
   Table 38: US Historic Review for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-181$200
   Table 39: US 14-Year Perspective for Biophotonics by End-Use Sector - Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-191$200
   A. Market Analysis.....III-20
Outlook.....III-20
Rising Incidence of Cancer – A Business Case for Biophotonics.....III-20
1$75
   Table 40: New Cancer Cases in Canada by Gender and Affected Site: 2014 (includes corresponding Graph/Chart).....III-211$200
   Table 41: New Cancer Cases in Canada by Province: 2014 (includes corresponding Graph/Chart).....III-221$200
   Table 42: New Cancer Cases in Canada by Age Group: 2014 (includes corresponding Graph/Chart).....III-231$200
   Table 43: Cancer Related Deaths in Canada by Gender and Affected Site: 2014 (includes corresponding Graph/Chart).....III-241$200
   Table 44: Cancer Related Deaths in Canada by Province: 2014 (includes corresponding Graph/Chart).....III-251$200
   Table 45: Cancer Related Deaths in Canada by Age Group: 2014 (includes corresponding Graph/Chart).....III-26
Increasing Penetration of DM – An Opportunity for Biophotonics.....III-26
1$200
   Table 46: Prevalence of Diabetes Mellitus in Canada: 2014.....III-27
Product Launch.....III-27
1$200
   B. Market Analytics.....III-28
Table 47: Canadian Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-28
1$200
   Table 48: Canadian Historic Review for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-291$200
   Table 49: Canadian 14-Year Perspective for Biophotonics by End-Use Sector - Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-301$200
   A. Market Analysis.....III-31
Outlook.....III-31
Rising Cancer and Diabetes Cases Provide Growth Opportunity.....III-31
1$75
   Table 50: Cancer Related Deaths by Age Groups: 2013 (includes corresponding Graph/Chart).....III-321$200
   Table 51: Prevalence of Diabetes Mellitus in Japan (2014).....III-33
Select Players.....III-33
1$200
   B. Market Analytics.....III-34
Table 52: Japanese Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-34
1$200
   Table 53: Japanese Historic Review for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-351$200
   Table 54: Japanese 14-Year Perspective for Biophotonics by End-Use Sector - Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-361$200
   A. Market Analysis.....III-37
Market Overview.....III-37
Aging Population & Rising Incidence of Chronic Diseases to Drive Growth.....III-37
2$150
   Table 55: Population Breakup by Age Group for Select European Countries: 2012 (as a Percentage of Total Population) (includes corresponding Graph/Chart).....III-39
Cancer and Diabetes Mellitus in Europe: Key Statistics.....III-39
1$200
   Table 56: European Predicted Cancer Deaths in 2014: Number of Deaths by Gender and Major Cancer Type (includes corresponding Graph/Chart).....III-401$200
   Table 57: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in Europe by Country/Territory (2014) (In 000 People & %) (includes corresponding Graph/Chart).....III-411$200
   Product Launch.....III-42
B. Market Analytics.....III-42
Table 58: European Recent Past, Current and Future Analysis for Biophotonics by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-42
1$200
   Table 59: European Historic Review for Biophotonics by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-431$200
   Table 60: European 14-Year Perspective for Biophotonics by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-441$200
   Table 61: European Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-451$200
   Table 62: European Historic Review for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-461$200
   Table 63: European 14-Year Perspective for Biophotonics by End-Use Sector - Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-471$200
   A. Market Analysis.....III-48
Outlook.....III-48
Corporate Development.....III-48
CEA-LETI – A Key Player.....III-48
1$75
   B. Market Analytics.....III-49
Table 64: French Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-49
1$200
   Table 65: French Historic Review for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-501$200
   Table 66: French 14-Year Perspective for Biophotonics by End-Use Sector - Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-511$200
   A. Market Analysis.....III-52
Outlook.....III-52
Strategic Corporate Developments.....III-52
1$75
   Select Players.....III-531$75
   B. Market Analytics.....III-54
Table 67: German Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-54
1$200
   Table 68: German Historic Review for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-551$200
   Table 69: German 14-Year Perspective for Biophotonics by End-Use Sector - Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-561$200
   Market Analysis.....III-57
Market Analysis.....III-57
1$75
   Table 70: Italian Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-581$200
   Table 71: Italian Historic Review for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-591$200
   Table 72: Italian 14-Year Perspective for Biophotonics by End-Use Sector - Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-601$200
   Market Analysis.....III-61
Market Analysis.....III-61
1$75
   Table 73: UK Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-621$200
   Table 74: UK Historic Review for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-631$200
   Table 75: UK 14-Year Perspective for Biophotonics by End-Use Sector - Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-641$200
   A. Market Analysis.....III-65
Outlook.....III-65
Select Players.....III-65
1$75
   B. Market Analytics.....III-66
Table 76: Spanish Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-66
1$200
   Table 77: Spanish Historic Review for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-671$200
   Table 78: Spanish 14-Year Perspective for Biophotonics by End-Use Sector - Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-681$200
   A. Market Analysis.....III-69
Outlook.....III-69
INJECT ENTERPRISE – A Major Player.....III-69
1$75
   B. Market Analytics.....III-70
Table 79: Russian Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-70
1$200
   Table 80: Russian Historic Review for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-711$200
   Table 81: Russian 14-Year Perspective for Biophotonics by End-Use Sector - Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-721$200
   A. Market Analysis.....III-73
Outlook.....III-73
Key Players.....III-73
2$150
   B. Market Analytics.....III-75
Table 82: Rest of Europe Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-75
1$200
   Table 83: Rest of Europe Historic Review for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-761$200
   Table 84: Rest of Europe 14-Year Perspective for Biophotonics by End-Use Sector - Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-771$200
   A. Market Analysis.....III-78
Outlook.....III-78
Increasing Prevalence of Diabetes to Drive Biophotonics Market.....III-78
1$75
   Diabetes Statistics in Asia-Pacific – Opportunity Indicators.....III-79
Table 85: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in Southeast Asia (2014): Breakdown by Country/ Territory (in 000 People & %) (includes corresponding Graph/Chart).....III-79
1$200
   Table 86: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in Western Asia by Country/Territory (2014) (In 000s & %).....III-801$200
   Table 87: Incidence of Type 1 Diabetes in Children by Select Countries in Western Pacific (2012) (includes corresponding Graph/Chart).....III-81
China.....III-81
1$200
   Strategic Corporate Developments.....III-82
Zecotek Photonics, Inc. – A Major Player.....III-82
1$75
   B. Market Analytics.....III-83
Table 88: Asia-Pacific Recent Past, Current and Future Analysis for Biophotonics by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-83
1$200
   Table 89: Asia-Pacific Historic Review for Biophotonics by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-841$200
   Table 90: Asia-Pacific 14-Year Perspective for Biophotonics by Geographic Region - Percentage Breakdown of Revenues for China, India, and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-851$200
   Table 91: Asia-Pacific Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-861$200
   Table 92: Asia-Pacific Historic Review for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-871$200
   Table 93: Asia-Pacific 14-Year Perspective for Biophotonics by End-Use Sector - Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-881$200
   A. Market Analysis.....III-89
Outlook.....III-89
Rising Incidence of Diabetes in Latin America – Opportunity Indicator.....III-89
1$75
   Table 94: Prevalence of Diabetes Mellitus in South & Central America (2013 & 2035): Breakdown by Country and Age Group (In 000 People & %) (includes corresponding Graph/Chart).....III-901$200
   B. Market Analytics.....III-91
Table 95: Latin America Recent Past, Current and Future Analysis for Biophotonics by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-91
1$200
   Table 96: Latin America Historic Review for Biophotonics by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-921$200
   Table 97: Latin America 14-Year Perspective for Biophotonics by Geographic Region - Percentage Breakdown of Revenues for Brazil, and Rest of Latin America Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-931$200
   Table 98: Latin America Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-941$200
   Table 99: Latin America Historic Review for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-951$200
   Table 100: Latin America 14-Year Perspective for Biophotonics by End-Use Sector - Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-961$200
   A. Market Analysis.....III-97
Outlook.....III-97
Increasing Incidence of Chronic Conditions: Opportunity for Biophotonics.....III-97
1$75
   Diabetes Prevalence Statistics.....III-98
Table 101: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in Africa (2014): Breakdown by Country/Territory (in 000 People & %) (includes corresponding Graph/Chart).....III-98
1$200
   Table 102: Prevalence of Diabetes Mellitus in Middle East & North Africa (2014): Breakdown by Country/Territory and Age Group (in 000 People & %) (includes corresponding Graph/Chart).....III-991$200
   Table 103: African Population and Diabetes Prevalence Statistics (2013) - Select Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart).....III-1001$200
   Table 104: Middle East and North African Population and Diabetes Prevalence Statistics (2013 Estimates) - Select Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart).....III-1011$200
   Product Launches.....III-102
Lumenis ltd. (Israel) – A Key Player.....III-102
1$75
   B. Market Analytics.....III-103
Table 105: Rest of World Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-103
1$200
   Table 106: Rest of World Historic Review for Biophotonics by End-Use Sector - Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1041$200
   Table 107: Rest of World 14-Year Perspective for Biophotonics by End-Use Sector - Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1051$200
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com